“…Although it is ubiquitous in the environment and primary C. neoformans infection is acquired in childhood (1,26,61), cryptococcal disease (cryptococcosis) occurs predominantly in immunocompromised hosts (10), such as patients with AIDS (64) or hematological malignancies (49,56), patients receiving chemotherapy for malignancy (45) or immunosuppressive agents for organ transplantation (29,63), and those with underlying metabolic disorders (14,32). Recently, it has come to light that, in addition to occurring in the setting of immunosuppression, cryptococcosis also can stem from an exuberant immune response (11,19), such as that seen after immune reconstitution in AIDS patients on antiretroviral therapy (30) and in solid-organ transplant recipients (59).…”